EUVIMEDEUVIMED entdecken
Crossref

Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical Trials

Anita J Campbell, Keerthi Anpalagan, Emma J Best, Philip N Britton, Amanda Gwee, James Hatcher, Brett J Manley, Julie Marsh, Rachel H Webb, Joshua S Davis, Robert K Mahar, Anna McGlothlin und 15 weitere

JAMA Pediatrics · 2024

DOI: 10.1001/jamapediatrics.2024.2697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Pediatrics, 2024. Verfasst von Anita J Campbell und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Bayes Theorem. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance There is a recognized unmet need for clinical trials to provide evidence-informed care for infants, children and adolescents. This Special Communication outlines the capacity of 3 distinct trial design strategies, sequential, parallel, and a unified adult-pediatric bayesian adaptive design, to incorporate children into clinical trials and transform this current state of evidence inequity. A unified adult-pediatric whole-of-life clinical trial is demonstrated through the Staphylococcus aureus Network Adaptive Platform (SNAP) trial. Observations Bayesian methods provide a framework for synthesizing data in the form of a probability model that can be used in the design and analysis of a clinical trial. Three trial design strategies are compared: (1) a sequential adult-pediatric bayesian approach that involves a separate, deferred pediatric trial that incorporates existing adult trial data into the analysis model to potentially reduce the pediatric trial sample size; (2) a parallel adult-pediatric bayesian trial whereby separate pediatric enrollment occurs in a parallel trial, running alongside an adult randomized clinical trial; and (3) a unified adult-pediatric bayesian adaptive design that supports the enrollment of both children and adults simultaneously in a whole-of-life bayesian adaptive randomized clinical trial. The SNAP trial whole-of-life design uses a bayesian hierarchical model that allows information sharing (also known as borrowing) between trial age groups by linking intervention effects of children and adults, thereby improving inference in both groups. Conclusion and Relevance Bayesian hierarchical models may provide more precision for estimates of safety and efficacy of treatments in trials with heterogenous populations compared to traditional methods of analysis. They facilitate the inclusion of children in clinical trials and a shift from children deemed therapeutic orphans to the vision of no child left behind in clinical trials to ensure evidence for clinical practice exists across the life course. The SNAP trial provides an example of a bayesian adaptive whole-of-life inclusion design that enhances trial population inclusivity and diversity overall, as well as generalizability and translation of findings into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bayes TheoremHumansChildAdolescentResearch DesignAdultClinical Trials as TopicPatient SelectionStaphylococcal InfectionsInfantAdaptive Clinical Trials as Topic

Autor:innen und Institutionen

  • Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.
  • Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia.
  • School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
  • Department of Paediatrics, Child and Youth Health, The University of Auckland, Auckland, New Zealand.
  • The National Immunisation Advisory Centre, The University of Auckland, Auckland, New Zealand.
  • Department of Infectious Diseases, Starship Children's Hospital, Auckland, New Zealand.

Zitieren

APA

Campbell, A. J., Anpalagan, K., Best, E. J., Britton, P. N., Gwee, A., Hatcher, J., Manley, B. J., Marsh, J., Webb, R. H., Davis, J. S., Mahar, R. K., McGlothlin, A., McMullan, B., Meyer, M., Mora, J., Murthy, S., Nourse, C., Papenburg, J., Schwartz, K. L., …, & Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee (2024). Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical Trials. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2024.2697

Vancouver

Campbell AJ, Anpalagan K, Best EJ, Britton PN, Gwee A, Hatcher J, et al. Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical Trials. JAMA Pediatrics. 2024. doi:10.1001/jamapediatrics.2024.2697

BibTeX
@article{Campbell2024,
  author = {Campbell, Anita J and Anpalagan, Keerthi and Best, Emma J and Britton, Philip N and Gwee, Amanda and Hatcher, James and Manley, Brett J and Marsh, Julie and Webb, Rachel H and Davis, Joshua S and Mahar, Robert K and McGlothlin, Anna and McMullan, Brendan and Meyer, Michael and Mora, Jocelyn and Murthy, Srinivas and Nourse, Clare and Papenburg, Jesse and Schwartz, Kevin L and Scheuerman, Oded and Snelling, Thomas and Strunk, Tobias and Stark, Michael and Voss, Lesley and Tong, Steven Y C and Bowen, Asha C and Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee, Staphylococcus aureus Network Adaptive Platform Paediatric and Youth (SNAP-PY) working groupSNAP Global Trial Steering Committee},
  title = {Whole-of-Life Inclusion in Bayesian Adaptive Platform Clinical Trials},
  journal = {JAMA Pediatrics},
  year = {2024},
  doi = {10.1001/jamapediatrics.2024.2697}
}
Kostenlos starten →